We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+11.68%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$51B
AUM Growth
+$4.88B
(+11%)
Cap. Flow
+$834M
Cap. Flow
% of AUM
1.63%
Top 10 Holdings %
Top 10 Hldgs %
25.68%
Holding
986
New
26
Increased
432
Reduced
416
Closed
39
Avg Time Held
4.6
years
Top 10 Avg Time Held
3.2
years
Top 20 Avg Time Held
2.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kaspi.kz JSC
KSPI
|
+$260M |
| 2 |
Microsoft
MSFT
|
+$71.2M |
| 3 |
Cardinal Health
CAH
|
+$61.4M |
| 4 |
Clorox
CLX
|
+$47.7M |
| 5 |
Accenture
ACN
|
+$46.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sociedad Química y Minera de Chile
SQM
|
+$63.6M |
| 2 |
Splunk Inc
SPLK
|
+$56.2M |
| 3 |
L3Harris
LHX
|
+$46.8M |
| 4 |
Crown Holdings
CCK
|
+$43M |
| 5 |
Fomento Económico Mexicano
FMX
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.39% |
| 2 | Healthcare | 17.34% |
| 3 | Financials | 11.02% |
| 4 | Consumer Discretionary | 9.2% |
| 5 | Industrials | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
976
Nebius Group N.V.
NBIS
$51.2B
| $0 | ﹤0.01% |
76,441
+7,785
| +11% | – |
2017 Q3
26 quarters
|
|
977
JOYY Inc
JOYY
$4.07B
| – | – |
-9,694
| Closed | -$385K | – |
|
978
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| – | – |
-21,697
| Closed | -$209K | – |
|
|
CPE
979
DELISTED
Callon Petroleum Company
CPE
| – | – |
-423,405
| Closed | -$13.7M | – |
|
980
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| – | – |
-32,217
| Closed | -$10.2M | – |
|
|
981
DELISTED
Splunk Inc
SPLK
| – | – |
-369,213
| Closed | -$56.2M | – |
|
|
MDRX
982
DELISTED
Veradigm Inc. Common Stock
MDRX
| – | – |
-428,580
| Closed | -$4.5M | – |
|
|
SRC
983
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| – | – |
-26,034
| Closed | -$1.14M | – |
|
984
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| – | – |
-16,102
| Closed | -$207K | – |
|
|
HARP
985
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| – | – |
-25,991
| Closed | -$296K | – |
|
986
DELISTED
PHYSICIANS REALTY TRUST
DOC
| – | – |
-919,351
| Closed | -$12.2M | – |
|
Similar funds
Aberdeen Group's Q1 2024 Portfolio in Review
As of Q1 2024, Aberdeen Group held 986 positions worth $51B, up 11% from $46.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Aberdeen Group's Q1 2024 filing shows 26 new, 432 increased, 416 reduced and 39 closed positions. Its largest new stake was Kaspi.kz JSC: 2,541,596 shares worth $327M. The largest sale was Sociedad Química y Minera de Chile, an estimated $63.6M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- Aberdeen Group's largest Q1 2024 buy was Kaspi.kz JSC: 2,541,596 shares worth $327M.
- Aberdeen Group added most to Microsoft in Q1 2024, an estimated $71.2M increase.
- Aberdeen Group's biggest Q1 2024 reduction was Sociedad Química y Minera de Chile, cutting an estimated $63.6M.
- Aberdeen Group fully exited Splunk Inc in Q1 2024, selling an estimated $56.2M.
- Aberdeen Group's ten largest holdings make up 26% of its $51B portfolio in Q1 2024.
- Aberdeen Group opened 26 new positions and closed 39 in Q1 2024.
- Aberdeen Group's portfolio value rose 11% quarter-over-quarter to $51B.
Based on Aberdeen Group's 13F filing for Q1 2024, filed 9 May 2024.